Search

everythinglearnresearchcommunity

for

Search:↓

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Possible link between androgens and COVID-19 severity; more research needed.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.